312 related articles for article (PubMed ID: 22841130)
1. Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes.
Carpentier PJ; Arias Vasquez A; Hoogman M; Onnink M; Kan CC; Kooij JJ; Makkinje R; Iskandar S; Kiemeney LA; de Jong CA; Franke B; Buitelaar JK
Eur Neuropsychopharmacol; 2013 Jun; 23(6):448-57. PubMed ID: 22841130
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).
Sánchez-Mora C; Ramos-Quiroga JA; Garcia-Martínez I; Fernàndez-Castillo N; Bosch R; Richarte V; Palomar G; Nogueira M; Corrales M; Daigre C; Martínez-Luna N; Grau-Lopez L; Toma C; Cormand B; Roncero C; Casas M; Ribasés M
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1463-73. PubMed ID: 23906647
[TBL] [Abstract][Full Text] [Related]
3. COMT Val158Met variant and functional haplotypes associated with childhood ADHD history in women with bulimia nervosa.
Yilmaz Z; Kaplan AS; Zai CC; Levitan RD; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):948-52. PubMed ID: 21300128
[TBL] [Abstract][Full Text] [Related]
4. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1.
Ribasés M; Ramos-Quiroga JA; Hervás A; Sánchez-Mora C; Bosch R; Bielsa A; Gastaminza X; Lesch KP; Reif A; Renner TJ; Romanos M; Warnke A; Walitza S; Freitag C; Meyer J; Palmason H; Casas M; Bayés M; Cormand B
World J Biol Psychiatry; 2012 Apr; 13(4):281-92. PubMed ID: 22404661
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the presence of ADHD and certain candidate gene polymorphisms in a Turkish sample.
Pazvantoğlu O; Güneş S; Karabekiroğlu K; Yeğin Z; Erenkuş Z; Akbaş S; Sarısoy G; Korkmaz IZ; Böke O; Bağcı H; Sahin AR
Gene; 2013 Oct; 528(2):320-7. PubMed ID: 23872233
[TBL] [Abstract][Full Text] [Related]
6. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
7. [Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].
Zhang XN; Ruan LM; Le YP; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):322-4. PubMed ID: 12903043
[TBL] [Abstract][Full Text] [Related]
8. ADHD candidate gene study in a population-based birth cohort: association with DBH and DRD2.
Nyman ES; Ogdie MN; Loukola A; Varilo T; Taanila A; Hurtig T; Moilanen IK; Loo SK; McGough JJ; Järvelin MR; Smalley SL; Nelson SF; Peltonen L
J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1614-21. PubMed ID: 18030083
[TBL] [Abstract][Full Text] [Related]
9. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
Eisenberg J; Mei-Tal G; Steinberg A; Tartakovsky E; Zohar A; Gritsenko I; Nemanov L; Ebstein RP
Am J Med Genet; 1999 Oct; 88(5):497-502. PubMed ID: 10490706
[TBL] [Abstract][Full Text] [Related]
10. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.
Payton A; Holmes J; Barrett JH; Hever T; Fitzpatrick H; Trumper AL; Harrington R; McGuffin P; O'Donovan M; Owen M; Ollier W; Worthington J; Thapar A
Am J Med Genet; 2001 Jul; 105(5):464-70. PubMed ID: 11449400
[TBL] [Abstract][Full Text] [Related]
11. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
[TBL] [Abstract][Full Text] [Related]
12. Impaired temporal resolution of visual attention and dopamine beta hydroxylase genotype in attention-deficit/hyperactivity disorder.
Bellgrove MA; Mattingley JB; Hawi Z; Mullins C; Kirley A; Gill M; Robertson IH
Biol Psychiatry; 2006 Nov; 60(10):1039-45. PubMed ID: 16876143
[TBL] [Abstract][Full Text] [Related]
13. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
[TBL] [Abstract][Full Text] [Related]
14. Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders?
Sizoo B; van den Brink W; Franke B; Vasquez AA; van Wijngaarden-Cremers P; van der Gaag RJ
World J Biol Psychiatry; 2010 Aug; 11(5):699-708. PubMed ID: 20446882
[TBL] [Abstract][Full Text] [Related]
15. Association of OPRM1 rs1799971, HTR1B rs6296 and COMT rs4680 polymorphisms with clinical phenotype among women with fibromyalgia.
Fernández-de-Las-Peñas C; Ambite-Quesada S; Fernández-Méndez LM; Jiménez-Antona C; Gómez-Calero C; Pocinho R; Valera-Calero JA; Cigarán-Méndez M; Arendt-Nielsen L
Sci Rep; 2024 May; 14(1):11273. PubMed ID: 38760456
[TBL] [Abstract][Full Text] [Related]
16. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
[TBL] [Abstract][Full Text] [Related]
17. Role of gene-gene/gene-environment interaction in the etiology of eastern Indian ADHD probands.
Das M; Das Bhowmik A; Bhaduri N; Sarkar K; Ghosh P; Sinha S; Ray A; Chatterjee A; Mukhopadhyay K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):577-87. PubMed ID: 21216270
[TBL] [Abstract][Full Text] [Related]
18. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study.
Smith KM; Daly M; Fischer M; Yiannoutsos CT; Bauer L; Barkley R; Navia BA
Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):77-85. PubMed ID: 12707943
[TBL] [Abstract][Full Text] [Related]
19. Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood.
Grünblatt E; Geissler J; Jacob CP; Renner T; Müller M; Bartl J; Gross-Lesch S; Riederer P; Lesch KP; Walitza S; Gerlach M; Schmitt A
Atten Defic Hyperact Disord; 2012 Jun; 4(2):77-84. PubMed ID: 22562805
[TBL] [Abstract][Full Text] [Related]
20. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes.
Ettinger U; Joober R; DE Guzman R; O'driscoll GA
Psychiatry Clin Neurosci; 2006 Dec; 60(6):764-7. PubMed ID: 17109713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
